StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 4M, up 29.9% from the year before. The highest annual figure on record is 4M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20254M+29.9%
FY2024Dec 31, 20243M+0.1%
FY2023Dec 31, 20233M+500.5%
FY2022Dec 31, 20220M+65.4%
FY2021Dec 31, 20210M+71.0%
FY2020Dec 31, 20200M+1.8%
FY2019Dec 31, 20190M+9.6%
FY2018Dec 31, 20180M–

More NewcelX figures

See a number that looks wrong?